Company news

Adocia SA news in 2025

Adocia SA's news releases, calls and decks from 2025, newest first.

View company

ADOCIA Announces its Financial Calendar for 2026

December 18, 2025

ADOCIA Announces the Completion of a €10 Million Fundraising

December 4, 2025

ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong™ - and Provides an Update on its BioChaperone® Platform

November 12, 2025

ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update

October 15, 2025

ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T1D

October 15, 2025

ADOCIA Announces First Half 2025 Financial Results and Provides a Business Update

September 25, 2025

ADOCIA Announces Oral Presentations on AdoShell® and BioChaperone® at EASD, ESB and PODD 2025 Annual Meetings

September 3, 2025

ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in People with T2D

July 25, 2025

ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update

July 23, 2025

ADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell® from Human Islets to Stem Cell-Derived Islets

June 24, 2025

ADOCIA Confirms its Eligibility for the PEA‑PME Scheme

May 22, 2025

ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 11th, 2025 in Paris

May 21, 2025

ADOCIA Reports First Quarter 2025 Financial Results and Provides a Business Update

May 14, 2025

ADOCIA to Present New Data on AdoShell® at Upcoming Scientific Conferences – Showcasing Potential Curative Treatment for Type 1 Diabetes

April 28, 2025

Decks in 2025